Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Drug Metabolism and Pharmacokinetics|September 5, 2012
Genome-wide association study reveals a complex genetic architecture underpinning-induced CYP3A4 enzyme activityNilufer Rahmioglu, James Heaton, Gail Clement, et al.Journal of Proteome Research|April 16, 2011
Prediction of variability in CYP3A4 induction using a combined 1H NMR metabonomics and targeted UPLC-MS approachNilufer Rahmioglu, Gwénaëlle Le Gall, James Heaton, et al.Pharmacogenetics and Genomics|July 14, 2011
Genetic epidemiology of induced CYP3A4 activityNilufer Rahmioglu, James Heaton, Gail Clement, et al.Molecular Pharmaceutics|March 3, 2021
Investigating the Impact of Crohn's Disease on the Bioaccessibility of a Lipid-Based Formulation with an In Vitro Dynamic Gastrointestinal ModelAngela Effinger, Mark McAllister, Irena Tomaszewska, et al.Neurobiology of Aging|September 18, 2013
Evidence of altered phosphatidylcholine metabolism in Alzheimer's diseaseLuke Whiley, Arundhuti Sen, James Heaton, et al.The Lancet. Infectious Diseases|June 20, 2021
Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trialAlistair R D McLean, Chanida Indrasuta, Zay Soe Khant, et al.The Lancet. Global Health|December 18, 2018
Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trialThomas Althaus, Rachel C Greer, Myo Maung Maung Swe, et al.Lancet (London, England)|March 15, 2020
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trialRob W van der Pluijm, Rupam Tripura, Richard M Hoglund, et al.Pageof 2